Table 2.
Donor ID | Age, Sex | Disease | Medical History |
---|---|---|---|
D16 | 59, f 1 | Angiomyolipoma | - |
D17 | 28, f | FNH 2 | IgA-nephropathy |
D18 | 28, m 3 | Echinococcosis | - |
D19 | 45, m | CRLM 4 | ulcerative colitis, s/p 5 colectomy |
D20 | 39, m | CRLM | recurrence |
D21 | 64, m | CRLM | CTx 6 |
D22 | 61, f | Metastasized cervix carcinoma | CTx, steatohepatitis |
D23 | 46, f | CRLM | CTx, steatohepatitis |
D24 | 78, m | CRLM | recurrence, CTx |
D25 | 72, m | pCCA 7 | s/p prostate cancer |
D26 | 42, f | Hereditary polycystic liver and kidney disease | immunosuppressive therapy |
D27 | 47, m | Liver abscess | infectious genesis, s/p adenocarcinoma |
D28 | 49, m | CRLM | in-situ split liver resection, avital tissue |
D29 | 66, m | Bile duct carcinoma | cholestasis, s/p PVE |
D30 | 74, m | pCCA | cholangitis |
D31 | 69, f | pCCA | s/p PVE 8, cholangitis |
D32 | 77, m | HCC 9 | urothelial carcinoma, obesity, intravesical CTx |
D33 | 47, f | Caroli disease | cholangitis, s/p acute hepatitis, s/p intraabdominal abscess, obesity |
1 f: female, 2 FNH: focal nodular hyperplasia, 3 m: male, 4 CRLM: colorectal liver metastasis, 5 s/p: status post, 6 CTx: chemotherapy, 7 pCCA: perihilar cholangiocarcinoma, 8 PVE: portal vein embolization, 9 HCC: hepatocellular carcinoma.